New Developments in Cardiology 2024
This course is designed to present new developments in the field of cardiovascular disorders and their clinical applications to encourage discussion and promote improved patient outcomes in all our practices. We have chosen topics and presenters to cover the latest in familiar topics as well as map out areas of frontier exploration. This activity is designed for family practitioners, internists, cardiologists, emergency department physicians, and advanced practice clinicians as well as other interested health professionals.
This conference is being held in-person.
Target Audience
This course is intended for physicians, advanced practice clinicians, nurses, and other interested health professionals.
Learning Objectives
At the end of this session, learners should be able to:
- Identify current treatments in five most common vascular problems
- Interpret the indications for action in treating cardiovascular disease
- Compare new treatments in cardiovascular disease
Agenda
7:00 to 7:55 am | Breakfast and Exhibits |
7:55 to 8:00 am | Welcome and Introductions |
8:00 to 8:30 am | Atrial Fibrillation: Rate vs Rhythm Control |
8:30 to 9:00 am | Syncope & Long QT syndrome: Diagnosis & Treatment |
9:00 to 9:30 am | Stroke Prevention in Atrial Fibrillation - Anticoagulation vs LAAO |
9:30 to 10:00 am | Beyond LDL: New Frontiers for Reducing your Patients Risk of MI, Stroke, and Death |
10:00 to 10:15 am | Break and Exhibits |
10:15 to 10:45 am | Update on Treatment Options for Mitral Valve Disease |
10:45 to 11:15 am | Updates and Treatment Options for Tricuspid Valve Disease |
11:15 to 11:45 am | Current Updates and Guidelines in Cardio Oncology |
11:45 am to 12:45 pm | Lunch and Exhibits |
12:45 to 1:15 pm | Hypertrophic Obstructive Cardiomyopathy - Prevalence, Diagnosis, Updates on Treatment Strategies |
1:15 to 1:45 pm | Type 2 Thoracic Aneurysm and Dissection: Upcoming Treatment Strategies |
1:45 to 2:15 pm | Updates in Etiology, Classification: Diagnosis and Treatment of Pulmonary Embolism |
2:15 to 2:45 pm | ST Elevation Myocardial Infarction |
2:45 to 3:15 pm | Peripheral Arterial Disease: Updates on Treatment Options |
3:15 to 3:45 pm | Pre-operative Assessment and Risk Stratification for Non-Cardiac Surgery |
3:45 pm | Adjourn |
Faculty
Activity Directors:
Tanvir Bajwa, MD, FACC, FSCAI; Clinical Adjunct Professor of Medicine, Associate, Head, Cardiovascular Disease Section, Director, Cardiac Catheterization Laboratory, Director, Interventional Fellowship Program, Aurora St. Luke’s Medical Center
Suhail Allaqaband, MD, FACC, FACAI, FCCP; Clinical Adjunct Professor of Medicine, Program Director, Cardiology Fellowship Program, Director Cardiac, Catheterization Laboratory, Aurora St. Luke’s Medical Center
Jayant Khitha, MD, FAAC, FSCAI, FCCP; Interventionalist, Cardiac, Vascular & Endovascular; Associate Program Director, Cardiovascular Disease Fellowship, Aurora St. Luke’s Medical Center
Faculty:
Afzal Ammar, MD; Cardiologist, Aurora St. Luke’s Medical Center
Alan Brown, MD - Interventional Cardiologist; Advocate Health – Downers Grove
Patrycja Galazka, MD; Advanced Cardiovascular Imaging, HCM, Aurora St. Luke’s Medical Center
Arshad Jahangir, MD; Electrophysiologist, Aurora St. Luke’s Medical Center
Fuad Jan, MD, MBBS, FACC; Interventional Cardiologist, Aurora St. Luke’s Medical Center
Louie Kostopoulos, MD; Interventional Cardiologist, Aurora St. Luke’s Medical Center
M. Eyman Mortada, MD, FACC, FHRS; Electrophysiologist, Aurora St. Luke’s Medical Center
Tonga Nfor, MD, MSPH, FACC, FSCAI; Interventional Cardiologist, Aurora St. Luke’s Medical Center
Manmeet Singh, MD; Advanced Heart Failure & Transplant Cardiologist, Aurora St. Luke’s Medical Center
Jodi Zilinski, MD; Electrophysiologist, Aurora St. Luke’s Medical Center
Disclosure
Faculty disclosures are being reviewed and will be presented to the audience in advance of the program.
Accreditation Statement
In support of improving patient care, Advocate Health is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Statement(s)
American Medical Association (AMA)
Advocate Health designates this live activity for a maximum of 6.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
American Nurses Credentialing Center (ANCC)
Advocate Health designates this live activity for a maximum of 6.50 ANCC contact hours. Nurses should claim only the credit commensurate with the extent of their participation in the activity.
Available Credit
- 6.50 AMA PRA Category 1 Credit™Aurora Health Care is accredited by the Wisconsin Medical Society to provide continuing medical education for physicians. Aurora Health Care designates this activity for a maximum of 6.50 AMA PRA Category 1 Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
- 6.50 AttendanceAttendance Credit
- 6.50 Approved AMA PRA Category 1 Credit™
- 6.50 Continuing Nursing Education (CE)Aurora Health Care is an approved provider of continuing nursing education by the Wisconsin Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. 6.50 contact hours have been awarded to this activity by the Wisconsin Nursing Association. To receive contact hours, participants must attend the entire activity.
Price
Please click on the options above and then click "Add to Cart".
NOTE: you can only pay by credit card.
Course Fees | Price |
Physician/DO/PhD/PharmD/Industry | $100.00 |
Advanced Practice Clinicians, RN's, other | $25.00 |
Fellows/Residents/Students | FREE |
If you have any questions, please contact the IPCE Office at cme@aah.org